Vincent
Guest
|
 Posted:
Mon Nov 14, 2005 5:00 pm Post subject:
Stock to watch --- IMMC |
|
|
Immunicon Corporation, a development stage company, engages in the
development, manufacture, marketing, and sale of cell and molecular-based
human diagnostic and life science research products with a focus on cancer.
It develops platform technologies for selection and analysis of rare cells
in blood, such as circulating tumor cells (CTC) and circulating endothelial
cells that are important in various diseases and biological processes. The
company primarily offers the CellSave preservative tube for the collection
and preservation of blood; and CellTracks AutoPrep system that consists of
reagents for use with its instruments and other system components, which
enable scientists, physicians, and laboratories to collect, isolate, label,
count, and analyze CTCs and other rare cells. Immunicon offers its products
principally in the United States, Europe, and Japan. It has collaboration
agreements with Veridex, LLC; Research and Diagnostic Systems, Inc.; Pfizer,
Inc.; igeneon; Molecular Probes, Inc.; Quest Diagnostics; and Ortho-Clinical
Diagnostics K.K. The company was founded in 1983 and is based in Huntingdon
Valley, Pennsylvania.
|
|
FAQ
Memberlist
Register
Profile
Log in to check your private messages
Log in
